Skip to main content
. 2022 Jul 28;108(1):9–21. doi: 10.3324/haematol.2022.281266

Table 1.

Approved and investigational PI3K inhibitors in chronic lymphocytic leukemia.

graphic file with name 1089.tab1.jpg